um, no Q does not suck. It’s a solid entrant into the sleep med market. The data is solid and the patient/ HCP feedback has been solid. Especially for 50mg, when taken every night. Yes it’s the third Dora to launch, but it is well differentiated.
if you really think the med sucks, then how can you promote with a clear conscience? U Should go elsewhere.
That said, I have many problems with the promotional strategy & how reps have been treated. That’s the problem, not the med. Threatening reps after 4 mos is absolutely unprecedented. And to continue hiring reps for territories know to have insufficient potential is shameful.